Author Index
Search or browse for an author across our entire electronic archive
Search results for: T
Results 131 - 140 of 1359 shown below
Takeda, H
H Takeda, H Miyoshi, Y Tamai, M Oshima and M M Taketo
Simultaneous expression of COX-2 and mPGES-1 in mouse gastrointestinal hamartomas
doi:10.1038/sj.bjc.6601584
Abstract | Full article | PDF
-
Y Takehara, H Sakahara, H Masunaga, S Isogai, N Kodaira, H Takeda, T Saga, S Nakajima and I Sakata
Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice
doi:10.1054/bjoc.2001.1802
Takeda, K
M Yamada, S Kudoh, H Fukuda, K Nakagawa, N Yamamoto, Y Nishimura, S Negoro, K Takeda, M Tanaka and M Fukuoka
Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
doi:10.1038/sj.bjc.6600464
Abstract | Full article | PDF
-
I Sekine, H Nokihara, K Takeda, Y Nishiwaki, K Nakagawa, H Isobe, K Mori, K Matsui, N Saijo and T Tamura
Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer
advance online publication, 2008-02-05 00:00:00.000;
doi:10.1038/sj.bjc.6604233
Abstract | Full article | PDF
-
H Kunitoh, T Tamura, T Shibata, K Nakagawa, K Takeda, Y Nishiwaki, Y Osaki, K Noda, A Yokoyama and N Saijo
A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605)
advance online publication, 2009-10-06 00:00:00.000;
doi:10.1038/sj.bjc.6605347
Abstract | Full article | PDF
-
K Takeda, S Negoro, S Kudoh, K Okishio, N Masuda, M Takada, M Tanaka, T Nakajima and T Tada
Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer
doi:10.1038/sj.bjc.6690233
-
L Ding, M Sunamura, T Kodama, J Yamauchi, D G Duda, H Shimamura, K Shibuya, K Takeda and S Matsuno
In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells
doi:10.1054/bjoc.2001.1911
Takeda, M
M Kimura, Y Tomita, T Imai, T Saito, A Katagiri, T Tanikawa, M Takeda and K Takahashi
Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
doi:10.1038/sj.bjc.6690576
Takeda, S
S Nomoto, T Kinoshita, K Kato, S Otani, H Kasuya, S Takeda, N Kanazumi, H Sugimoto and A Nakao
Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma
advance online publication, 2007-10-30 00:00:00.000;
doi:10.1038/sj.bjc.6604016
Abstract | Full article | PDF
-
S Nomoto, T Kinoshita, T Mori, K Kato, H Sugimoto, N Kanazumi, S Takeda and A Nakao
Adverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancer
advance online publication, 2008-05-13 00:00:00.000;
doi:10.1038/sj.bjc.6604333
Abstract | Full article | PDF
Takeda, T
Y Ito, N Matsuura, M Sakon, T Takeda, K Umeshita, H Nagano, S Nakamori, K Dono, M Tsujimoto, M Nakahara, K Nakao and M Monden
Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma
doi:10.1038/sj.bjc.6690758
-
Y Ito, M Monden, T Takeda, H Eguchi, K Umeshita, H Nagano, S Nakamori, K Dono, M Sakon, M Nakamura, M Tsujimoto, M Nakahara, K Nakao, Y Yokosaki and N Matsuura
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
doi:10.1054/bjoc.1999.1065
-
Y Ito, T Takeda, M Sakon, M Tsujimoto, S Higashiyama, K Noda, E Miyoshi, M Monden and N Matsuura
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
doi:10.1054/bjoc.2000.1580
Takeda, Y
Y Takeda, E Tsuduki, S Izumi, M Hojo, M Kamimura, G Naka, K Kobayashi and K Kudo
A phase I/II trial of irinotecan–cisplatin combined with an anti-late-diarrhoeal programme to evaluate the safety and antitumour response of this combination therapy in patients with advanced non-small-cell lung cancer
advance online publication, 2005-11-15 00:00:00.000;
doi:10.1038/sj.bjc.6602866
Abstract | Full article | PDF
-
T Noda, H Nagano, I Takemasa, S Yoshioka, M Murakami, H Wada, S Kobayashi, S Marubashi, Y Takeda, K Dono, K Umeshita, N Matsuura, K Matsubara, Y Doki, M Mori and M Monden
Activation of Wnt/
-catenin signalling pathway induces chemoresistance to interferon-
/5-fluorouracil combination therapy for hepatocellular carcinomaadvance online publication, 2009-04-28 00:00:00.000;
doi:10.1038/sj.bjc.6605064
Abstract | Full article | PDF
Takedatsu, H
K Azuma, S Shichijo, H Takedatsu, N Komatsu, H Sawamizu and K Itoh
Heat shock cognate protein 70 encodes antigenic epitopes recognised by HLA-B4601-restricted cytotoxic T lymphocytes from cancer patients
doi:10.1038/sj.bjc.6601203
Abstract | Full article | PDF
Takehara, Y
Y Takehara, H Sakahara, H Masunaga, S Isogai, N Kodaira, H Takeda, T Saga, S Nakajima and I Sakata
Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice
doi:10.1054/bjoc.2001.1802
Takei, H
J Horiguchi, H Takei, Y Koibuchi, K Iijima, J Ninomiya, K Uchida, R Ochiai, M Yoshida, T Yokoe, Y Iino and Y Morishita
Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer
doi:10.1038/sj.bjc.6600040
Abstract | Full article | PDF
Takei, Y
H Tanaka, N Fujita, R Sugimoto, N Urawa, S Horiike, Y Kobayashi, M Iwasa, N Ma, S Kawanishi, S Watanabe, M Kaito and Y Takei
Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C
advance online publication, 2008-01-29 00:00:00.000;
doi:10.1038/sj.bjc.6604204
Abstract | Full article | PDF
-
Result page:
- 1|
- 2|
- 3|
- 4|
- 5|
- 6|
- 7|
- 8|
- 9|
- 10|
- 11|
- 12|
- 13|
- 14|
- 15|
- 16|
- 17|
- 18|
- 19|
- 20|
- 21|
- 22|
- 23|
- 24|
- 25|
- 26|
- 27|
- 28|
- 29|
- 30|
- 31|
- 32|
- 33|
- 34|
- 35|
- 36|
- 37|
- 38|
- 39|
- 40|
- 41|
- 42|
- 43|
- 44|
- 45|
- 46|
- 47|
- 48|
- 49|
- 50|
- 51|
- 52|
- 53|
- 54|
- 55|
- 56|
- 57|
- 58|
- 59|
- 60|
- 61|
- 62|
- 63|
- 64|
- 65|
- 66|
- 67|
- 68|
- 69|
- 70|
- 71|
- 72|
- 73|
- 74|
- 75|
- 76|
- 77|
- 78|
- 79|
- 80|
- 81|
- 82|
- 83|
- 84|
- 85|
- 86|
- 87|
- 88|
- 89|
- 90|
- 91|
- 92|
- 93|
- 94|
- 95|
- 96|
- 97|
- 98|
- 99|
- 100|
- 101|
- 102|
- 103|
- 104|
- 105|
- 106|
- 107|
- 108|
- 109|
- 110|
- 111|
- 112|
- 113|
- 114|
- 115|
- 116|
- 117|
- 118|
- 119|
- 120|
- 121|
- 122|
- 123|
- 124|
- 125|
- 126|
- 127|
- 128|
- 129|
- 130|
- 131|
- 132|
- 133|
- 134|
- 135|
- 136|
- Next
